Synthetic Biologics Inc is a late-stage biotechnology company focused on developing gut microbiome therapeutics. It is also developing monoclonal antibody therapies for the treatment of pertussis.
$0.70
As of 02/23/2021 IEX book CBOE book
2021 © Stock Market MBA, Inc.